Concepedia

William J. Sasiela

WJ

Statistics

Publications

40

Citations

11.7K

H-Index

31

Active since

2003

Affiliations

Regeneron (United States)(Current)

Brigham and Women's Hospital

Sanofi (United States)

Sanofi (France)

Harvard University

William J. Sasiela is an author at Regeneron (United States) specializing in lipid-lowering therapy, clinical pharmacology, and pharmacology.

ORCID

Publications per year

2003–2024

40

Publications

40

Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome

Gregory G. Schwartz, Philippe Gabríel Steg, Michael Szarek et al. · New England Journal of Medicine · 2018 · 3.5K citations · Full text

, , +17

Statin Therapy, LDL Cholesterol, C-Reactive Protein, and Coronary Artery Disease

Steven E. Nissen, E. Murat Tuzcu, Paul Schoenhagen et al. · New England Journal of Medicine · 2005 · 1.3K citations

, , +17

Genetic and Pharmacologic Inactivation of ANGPTL3 and Cardiovascular Disease

Frederick E. Dewey, Viktoria Gusarova, Richard L. Dunbar et al. · New England Journal of Medicine · 2017 · 875 citations · Full text

, , +15

Bempedoic Acid and Cardiovascular Outcomes in Statin-Intolerant Patients

Steven E. Nissen, A. Michael Lincoff, Danielle M. Brennan et al. · New England Journal of Medicine · 2023 · 875 citations · Full text

, , +17

Efficacy and safety of a microsomal triglyceride transfer protein inhibitor in patients with homozygous familial hypercholesterolaemia: a single-arm, open-label, phase 3 study

Marina Cuchel, Emma A. Meagher, Hendrik du Toit Theron et al. · The Lancet · 2012 · 740 citations · Full text

, , +12

1–5 of 40